Demant A/S Stock

Demant A/S Financial Leverage

The Financial Leverage (Equity Multiplier) of Demant A/S (DEMANT.CO) as of Aug 4, 2026 is 3.97. In the previous year, Financial Leverage (Equity Multiplier) was 3.39 — a change of 17.01% (higher).

Financial Leverage

3.97

YoY

17.01%

Last updated:

Financial Leverage (Equity Multiplier) of Demant A/S is 2026 3.97 . Financial Leverage (Equity Multiplier) of Demant A/S was 2025 3.39 . It decreases by 17.01% higher compared to the previous year.
Access this data via the Eulerpool API
Get Free API Key

Demant A/S Stock analysis

What does Demant A/S do? Demant A/S is a Danish company that operates in the field of hearing technology. It was founded in 1904 and is headquartered in Smørum, Denmark. The company has several subsidiaries in various countries, including the USA, Germany, France, and China. The history of Demant began with the founding of the company Oticon by Hans Demant in Copenhagen in 1904. Oticon was the first company to manufacture and sell hearing aids. Since then, the company has evolved into a leading provider of hearing aids, cochlear implants, and assistive listening devices. Demant's business model is based on the development and marketing of hearing technology products. The company is divided into several business areas, including hearing aids, cochlear implants, and diagnostics and consumables. In the field of hearing aids, Demant offers a wide range of products tailored to the needs of different customer groups. These range from basic hearing aids to high-end products with artificial intelligence. Demant's cochlear implant system is a groundbreaking technology that enables deaf or hard-of-hearing individuals to hear. It consists of an implanted device and an external speech processor. Demant's diagnostics and consumables business includes a variety of products used by medical professionals for the diagnosis and treatment of hearing disorders. These include earplugs, audiometry devices, tympanometry devices, and others. Demant is also active in many other areas, including research, development, and production of hearing technology products. The company has a strong global network of partners, distributors, and customers that further strengthens its position as a leading provider of hearing technology products. Overall, Demant has developed a deep understanding of the needs and requirements of people with hearing problems through its commitment to excellence and innovation. With its wide range of products, global network, and deep commitment to customer satisfaction, Demant has become a trusted name in hearing technology. Demant A/S is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Demant A/S stock

Financial Leverage (Equity Multiplier) of Demant A/S is 3.97 in 2026.

Financial Leverage (Equity Multiplier) of Demant A/S changed from 3.39 to 3.97, representing a 17.01% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Financial Leverage (Equity Multiplier) Demant A/S since 2006 – with annual values, charts, and detailed analysis.

Financial leverage, also known as the equity multiplier, measures total assets relative to equity. Higher leverage amplifies both returns and risks.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Financial Leverage (Equity Multiplier)'s Demant A/S with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API
Get Free API Key

Leverage — Demant A/S

Debt-to-EquityNet Debt / EBITDAInterest CoverageCurrent RatioQuick RatioCash RatioDebt / AssetsFinancial LeverageEquity RatioLT Debt/EquityNet Debt/EquityDebt/EBITDADSCRFinancial Debt RatioOCF/DebtFCF/DebtNet Debt/FCFDebt/Market Cap

All Key Metrics — Demant A/S